نتایج جستجو برای: rrms

تعداد نتایج: 1132  

2017
A Traboulsee DKB Li R Tam G Zhao A Riddehough J Fang F Dangond L Kappos

Background Evolution of gadolinium-enhancing lesions into chronic black holes (CBH) may be reduced by interferon (IFN) therapy. Objective The objective of this paper is to assess the effect of IFN β-1a and placebo on CBH evolution and disability in patients with relapsing-remitting multiple sclerosis (RRMS), as well as CBH evolution in patients with secondary progressive multiple sclerosis (S...

Journal: :Psychiatria Danubina 2014
Rytis Leonavicius Virginija Adomaitiene

BACKGROUND Sleep disturbances in multiple sclerosis (MS) have received little research attention despite the potential influence it may have on the impact of the disease. The aim of this study was to evaluate the prevalence of sleep disturbances in a Lithuanian community sample of individuals with the relapsing remitting multiple sclerosis (RRMS) and its relation with depression, anxiety, and h...

Journal: :BMC Neurology 2008
Manuel Vazquez-Marrufo Javier J Gonzalez-Rosa Encarnacion Vaquero Pablo Duque Monica Borges Carlos Gomez Guillermo Izquierdo

BACKGROUND A possible method of finding physiological markers of multiple sclerosis (MS) is the application of EEG quantification (QEEG) of brain activity when the subject is stressed by the demands of a cognitive task. In particular, modulations of the spectral content that take place in the EEG of patients with multiple sclerosis remitting-relapsing (RRMS) and benign multiple sclerosis (BMS) ...

Journal: :Multiple Sclerosis Journal - Experimental, Translational and Clinical 2020

Journal: :European neurology 2008
Mark S Freedman Bruce Hughes Daniel D Mikol Randy Bennett Brian Cuffel Vamil Divan Nicole LaVallee Ahmad Al-Sabbagh

The treatment of relapsing-remitting multiple sclerosis (RRMS) has become more effective over the last decade with the advent of the currently available disease-modifying therapies (DMTs). Pivotal clinical studies differ in many characteristics, such that cross-comparisons of relative risk reductions are of limited value and can be misleading. Our objective was to compare the clinical efficacy ...

Journal: :NeuroImage 2006
Fuchun Lin Chunshui Yu Tianzi Jiang Kuncheng Li Chaozhe Zhu Wanlin Zhu Wen Qin Yunyun Duan Yun Xuan Hong Sun Piu Chan

It is difficult to completely differentiate patients with relapsing neuromyelitis optica (RNMO) from relapsing-remitting multiple sclerosis (RRMS) for their similarities in clinical manifestation. In this study, we proposed a novel approach, using two-dimensional histogram of apparent diffusion coefficient (ADC) and fractional anisotropy (FA) of the brain derived from diffusion tensor imaging (...

2016
Imke Metz Tim Beißbarth David Ellenberger Florence Pache Lidia Stork Marius Ringelstein Orhan Aktas Sven Jarius Brigitte Wildemann Hassan Dihazi Tim Friede Wolfgang Brück Klemens Ruprecht Friedemann Paul

OBJECTIVE To assess in an observational study whether serum peptide antibody reactivities may distinguish aquaporin-4 (AQP4) antibody (Ab)-positive and -negative neuromyelitis optica spectrum disorders (NMOSD) and relapsing-remitting multiple sclerosis (RRMS). METHODS We screened 8,700 peptides that included human and viral antigens of potential relevance for inflammatory demyelinating diseas...

2014
Clementina E. Cocuzza Fabrizio Piazza Rosario Musumeci Davide Oggioni Simona Andreoni Margherita Gardinetti Letizia Fusco Maura Frigo Paola Banfi Maria R. Rottoli Paolo Confalonieri Monica Rezzonico Maria T. Ferrò Guido Cavaletti Barbara Frigeni Nerina Mascoli Marta Conti Carlo Antozzi Francesca Andreetta Elena Ambrosoni Elsa Mainardi

The presence of Epstein-Barr Virus (EBV) DNA in cerebrospinal fluid (CSF) and peripheral blood (PB) samples collected from 55 patients with clinical and radiologically-active relapsing-remitting MS (RRMS) and 51 subjects with other neurological diseases was determined using standardized commercially available kits for viral nucleic acid extraction and quantitative EBV DNA detection. Both cell-f...

2016
Morten Stilund Mikkel Carstensen Gjelstrup Tove Christensen Holger Jon Møller Thor Petersen

OBJECTIVES This study aimed to examine the levels of the macrophage marker sCD163 and other biomarkers at the time of diagnosis of patients with either clinically isolated syndrome (CIS) or relapsing-remitting multiple sclerosis (RRMS), and assess relation to clinical indicators of prognosis, disease activity (DA), and changes in the levels of these biomarkers at follow-up. MATERIALS AND METH...

Journal: :Archives of neurology 2008
Peter Huppke Wiebke Stark Claudia Zürcher Brenda Huppke Wolfgang Brück Jutta Gärtner

BACKGROUND Natalizumab, a humanized monoclonal antibody raised against alpha4 integrins, is approved for treatment of active relapsing-remitting multiple sclerosis (RRMS) in adult patients. OBJECTIVE To determine the safety, effectiveness, and tolerability of natalizumab use in pediatric patients with MS. DESIGN Case report. SETTING Center for MS in childhood and adolescents, Göttingen, G...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید